Non-invasive ventilation mask

Non-invasive ventilation mask being tested on the frontline in London, Ontario

London Health Sciences Centre - 

Led by Lawson Health Research Institute, London Health Sciences Centre (LHSC), University Health Network (UHN) and General Dynamics Land Systems-Canada (GDLS-Canada), researchers have designed a non-invasive ventilation mask that could significantly reduce aerosolization – the production of airborne respiratory droplets that may contain viruses or bacteria – when trea

Dr. Blayne Welk

Dr. Blayne Welk, Scientist at Lawson Health Research Institute and Associate Professor at the Schulich School of Medicine & Dentistry at Western University

Results showed an increase in the number of new cases of dementia for patients being treated with an anticholinergic medication compared to those being treated with beta-3 agonists.

St. Joseph's Hospital - 

A study from Western University, Lawson Health Research Institute and ICES provides further evidence of a link between a common class of medications called anticholinergics and the onset of dementia.

Anticholinergic medications are those that act on the body’s cholinergic receptors, and are used to treat a range of conditions from allergies and nausea to overactive bladder and psychiatric disorders.

Dr. Chris McIntyre

Dr. Chris McIntyre, Scientist at Lawson Health Research Institute and Nephrologist at London Health Sciences Centre, is the first in the world to treat a patient with COVID-19 using a modified dialysis device.

Extracorporeal treatment reprograms white blood cells to fight inflammation

LHSC: Victoria Hospital - 

As part of a randomized controlled trial, a team from Lawson Health Research Institute is the first in the world to treat a patient with COVID-19 using a modified dialysis device. The device gently removes a patient’s blood, modifies white blood cells and returns them to fight hyperinflammation. It is being tested with critically ill patients at London Health Sciences Centre (LHSC)

Pages